Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354223 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens
A NA study of Myopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 4
- Study locations
NCT01354223: Completed NA study of Myopia, sponsored by CooperVision.
NCT01354223 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 90 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01354223, a NA study of Myopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study seeks to evaluate a new daily disposable contact lens compared to an existing daily disposable contact lens.
Primary Outcome
The primary safety endpoint are the objective slit lamp findings associated with the stenfilcon A contact lenses compared with those same findings reported as associated with the ocufilcon B contact lenses. The incidence of biomicroscopy findings (0=not present, 4=severe) over the duration of the study with the highest reported grade was chosen for each unique eye. Biomicroscopy measurements were obtained at Baseline (baseline visit) and All Follow-Ups (week 1 visit, week 2 visit, month 1 visit
Conditions Studied
Interventions
- DEVICE stenfilcon A contact lens
- DEVICE ocufilcon B contact lens
Study Locations (4)
California
- Eric M. White, OD, Inc. - San Diego
Michigan
- Vision Care Associates - East Lansing
Ohio
- Western Reserve Vision Care - Beachwood
Tennessee
- Primary Eyecare Group, P.C. - Brentwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01354223 record still lists
NCT01354223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which stenfilcon A contact lens is the first listed.
NCT01354223 reports a single indexed study location in California, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT01354223 about?
NCT01354223 is a clinical study titled "Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens". This study seeks to evaluate a new daily disposable contact lens compared to an existing daily disposable contact lens.
What is the current status of trial NCT01354223?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-10. Estimated completion is 2011-04.
What conditions does trial NCT01354223 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01354223?
The interventions under investigation include: stenfilcon A contact lens (DEVICE), ocufilcon B contact lens (DEVICE).
Who is sponsoring clinical trial NCT01354223?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01354223 being conducted?
This trial has 4 study locations across California, Michigan, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01354223's enrollment target sits among peer trials
90 41st of 90 higher than 47 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia